Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5845586 | Pulmonary Pharmacology & Therapeutics | 2016 | 36 Pages |
Abstract
Our results suggest that activation of CB1 receptors may suppress the ROS-mediated VLCF hypersensitivity through a mechanism that is at least partly distinct from the function of TRPA1 and P2X receptors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Chou-Ming Yeh, Ting Ruan, Yu-Jung Lin, Tien-Huan Hsu,